Pharma News
-
Japan approves first drug for ADA deficiency
Pharma | News | 0 Comment | 04 Apr, 2019
Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, has announced that it has acquired marketing approval for Revcovi 2.4 mg for intramuscular injection...Read more
-
Harvest One enters into supply agreement with Health House
Pharma | News | 0 Comment | 04 Apr, 2019
Harvest One Cannabis Inc. through its wholly-owned subsidiary Satipharm Ltd. has entered into an agreement to become a supplier to the renowned medicinal cannabis wholesale & distr...Read more
-
Chugai Pharma sells Ulcerlmin business to Fuji Chemical
Pharma | News | 0 Comment | 03 Apr, 2019
Chugai Pharmaceutical Co., Ltd., Tokyo and Fuji Chemical Industries Co., Ltd., Toyama announced that two companies entered into a business transfer agreement recently for Ulcerlmin®...Read more
-
Aptorum Group Limited announces appointment of Head of R&D and COO
Pharma | News | 0 Comment | 02 Apr, 2019
Aptorum Group Limited has announced the appointment of Dr. Thomas Wai-yip Lee as Head of Research and Development and Dr. Angel Siu-yan Ng as Chief Operating Officer of Aptorum, effective o...Read more
-
NMPA approves Novartis's Cosentyx for psoriasis patients
Pharma | News | 0 Comment | 03 Apr, 2019
Novartis, a global leader in immuno-dermatology and rheumatology, has announced that the China Health Authority NMPA approved Cosentyx (secukinumab), the first-in-class interleukin-17A (IL-...Read more
-
Merck’s KEYTRUDA receives approval in China
Pharma | News | 0 Comment | 02 Apr, 2019
Merck, known as MSD outside the United States and Canada, has announced that KEYTRUDA, Merck’s anti-PD-1 therapy, has been approved by the National Medical Products Administration (NM...Read more
-
Pulmatrix signs binding agreement with Cipla worth $22M
Pharma | News | 0 Comment | 02 Apr, 2019
Pulmatrix, Inc., a clinical stage biopharmaceutical company focused on developing novel inhaled therapeutics to serve unmet needs in respiratory disease, has announced its entry into a Bind...Read more
-
Pharma | News | 0 Comment | 01 Apr, 2019
Celgene Corporation has announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted positive opinions for two triplet regimens bas...Read more
-
Boehringer Ingelheim acquires ICD Therapeutics
Pharma | News | 0 Comment | 01 Apr, 2019
Boehringer Ingelheim has announced that it has acquired ICD Therapeutics. The acquisition includes rights to ICD’s innovative MacroDel biologics-delivery platform. Boehringer Ing...Read more
-
Shanghai to host the third China Pharma Week
Pharma | News | 0 Comment | 01 Apr, 2019
As a high-end conference and event week specially launched concurrently with CPhI China, organized by UBM EMEA, CCCMHPIE, and UBM Sinoexpo, China Pharma Week will take place for the third t...Read more
-
Daiichi Sankyo, AstraZeneca sign $6.9M deal for cancer drug
Pharma | News | 0 Comment | 29 Mar, 2019
Daiichi Sankyo Company, Limited has entered into a global development and commercialization agreement with AstraZeneca for Daiichi Sankyo's lead antibody drug conjugate (ADC), [fam-] trastu...Read more
-
Luye Pharma's Rykindo might be the first Chinese Innovative Drug to receive U.S. FDA approval
Pharma | News | 0 Comment | 29 Mar, 2019
Luye Pharma Group has announced submission of a new drug application (NDA) to the U.S. Food and Drug Administration for Rykindo, completed on March 28. Rykindo (LY03004) Risperidone Extende...Read more
-
CPhI Japan sees Japanese R&D reinvigorated with international partnerships proliferating
Pharma | News | 1 Comment | 29 Mar, 2019
CPhI Japan closes as a new wave of innovation is rising across the country, driven by structural and regulatory changes. A focus on removing long-list products, and the increased use of gen...Read more
-
Japan approves Gilead’s Biktarvy to treat HIV-1 Infection
Pharma | News | 0 Comment | 28 Mar, 2019
Gilead Sciences, announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Biktarvy® (bictegravir 50mg/emtricitabine 200mg/tenofovir alafena...Read more
-
WuXi STA's new facility passes European MPA GMP inspection
Pharma | News | 0 Comment | 27 Mar, 2019
STA Pharmaceutical Co., Ltd., (WuXi STA) - a subsidiary of WuXi AppTec - announces that its new drug product manufacturing facility in Shanghai Pilot Free Trade Zone has passed it...Read more
-
Novartis’ Mayzent gets FDA nod to treat multiple sclerosis
Pharma | News | 0 Comment | 27 Mar, 2019
Novartis has received the US Food and Drug Administration (FDA) approval of Mayzent® (siponimod) for the treatment of adults with relapsing forms of multiple sclerosis, including s...Read more
-
Lupin, YL Biologics receive PMDA approval for Etanercept biosimilar in Japan
Pharma | News | 0 Comment | 26 Mar, 2019
Lupin has announced that YL Biologics Limited (YLB), a joint venture between Lupin’s subsidiary Lupin Atlantis Holdings SA (LAHSA) and Yoshindo Inc. in Japan, and Lupin (through its J...Read more
-
LegoChem Biosciences, Takeda collaborate for immuno-oncology research
Pharma | News | 0 Comment | 25 Mar, 2019
LegoChem Biosciences has announced that it has entered a research collaboration and license agreement with Takeda Pharmaceutical for the development of antibody-drug conjugates in immuno-on...Read more
